|
Solid performance delivering reported underlying operating profit growth of 14.1% at constant exchange rate (CER)(20.0% at reported rate) |
|
Group revenue declined by 0.7% at CER (up 4.3% at reported rate) due to under-performance in the Netherlands, phasing of export orders and continuing supply issues in the US; adjusting for these items, revenue growth was 3.4% |
|
Improved gross margin from 52.1% to 56.5% |
|
Pipeline progressing as expected |
|
Completed three in-licensed product deals, one for the US and two for the EU |
|
Underlying diluted EPS for continuing operations at 16.94p, growth of 22.3% at CER (29.4% at reported rate) |
|
Interim dividend increased by 9.4% to 4.75p (2012: 4.34p) |
